Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus: A Phase-II Study

NCT03585530 is registered in ClinicalTrials.gov with Huai'an First People's Hospital as lead sponsor.

NCT NCT03585530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03585530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus: A Phase-II Study
Lead sponsor
Huai'an First People's Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
September 5, 2018
Completion date
March 15, 2022
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophagus squamous cell carcinoma